Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01693328
What this trial is testing

Patient Satisfaction and Quality of Life Impact - PecFent®

Who this might be right for
Breakthrough Cancer Pain
Archimedes Development Ltd 300
Large-scale testing (Phase 3)Study completedNCT01309386
What this trial is testing

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Who this might be right for
Neoplasms
Janssen Pharmaceutical K.K. 100
Testing effectiveness (Phase 2)Study completedNCT00586339
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT00753675
What this trial is testing

Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerGallbladder CancerCancer Of The Extrahepatic Bile Duct+1 more
Genzyme, a Sanofi Company 174
Testing effectiveness (Phase 2)Study completedNCT01831466
What this trial is testing

Tofacitinib Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPsoriasis
Pfizer 476
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438329
What this trial is testing

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,123
Early research (Phase 1)Study completedNCT01992341
What this trial is testing

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Who this might be right for
Advanced Solid Tumors
Amgen 35
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Very early researchStudy completedNCT02157831
What this trial is testing

Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Abramson Cancer Center at Penn Medicine 10
Large-scale testing (Phase 3)UnknownNCT01560195
What this trial is testing

Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

Who this might be right for
NSCLCNeutropeniaFebrile Neutropenia
Jiangsu HengRui Medicine Co., Ltd. 150
Not applicableNo Longer AvailableNCT00495066
What this trial is testing

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb
Large-scale testing (Phase 3)WithdrawnNCT01452295
What this trial is testing

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

Who this might be right for
Acute Liver Failure
Vital Therapies, Inc.
Early research (Phase 1)Study completedNCT00858377
What this trial is testing

First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+2 more
Amgen 95
Early research (Phase 1)UnknownNCT05830045
What this trial is testing

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 180
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Early research (Phase 1)Ended earlyNCT04614636
What this trial is testing

FT538 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAML, AdultMultiple Myeloma+1 more
Fate Therapeutics 42
Testing effectiveness (Phase 2)WithdrawnNCT00540332
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Who this might be right for
Head and Neck Cancer
Swedish Orphan Biovitrum
Testing effectiveness (Phase 2)Study completedNCT01638936
What this trial is testing

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Biotest Pharmaceuticals Corporation 64
Early research (Phase 1)Active Not RecruitingNCT04623944
What this trial is testing

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

Who this might be right for
Relapsed/Refractory AMLAML, AdultMDS+1 more
Nkarta, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01478581
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pharmacyclics LLC. 92
Next Page